Cizzle Biotechnology Holdings Plc (FRA:E7F0)
0.0165
0.00 (0.00%)
At close: Dec 4, 2025
FRA:E7F0 Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 0.18 | 0.37 | 0.14 | 0.48 | 0.88 | 0.01 | Upgrade
|
| Trading Asset Securities | - | 0.02 | 1.41 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 0.18 | 0.39 | 1.56 | 0.48 | 0.88 | 0.01 | Upgrade
|
| Cash Growth | -77.70% | -75.14% | 225.73% | -45.37% | 12400.00% | -45.38% | Upgrade
|
| Other Receivables | 0.07 | 0.08 | 0.11 | 0.1 | 0.05 | - | Upgrade
|
| Receivables | 0.07 | 0.08 | 0.11 | 0.1 | 0.05 | - | Upgrade
|
| Inventory | 0 | 0 | - | - | - | - | Upgrade
|
| Prepaid Expenses | - | 0.03 | 0.03 | 0.01 | 0.03 | 0 | Upgrade
|
| Other Current Assets | - | - | - | 0.12 | - | - | Upgrade
|
| Total Current Assets | 0.26 | 0.49 | 1.69 | 0.71 | 0.96 | 0.01 | Upgrade
|
| Property, Plant & Equipment | 0 | - | - | - | - | - | Upgrade
|
| Other Intangible Assets | - | - | - | 2.08 | 0.2 | - | Upgrade
|
| Total Assets | 0.26 | 0.49 | 1.69 | 2.79 | 1.16 | 0.01 | Upgrade
|
| Accounts Payable | 0.38 | 0.01 | 0.09 | 0.04 | 0.11 | 0 | Upgrade
|
| Accrued Expenses | - | 0.4 | 0.09 | 0.1 | 0.11 | 0.01 | Upgrade
|
| Short-Term Debt | 0.15 | - | - | - | - | 0.01 | Upgrade
|
| Total Current Liabilities | 0.53 | 0.41 | 0.19 | 0.15 | 0.22 | 0.02 | Upgrade
|
| Total Liabilities | 0.53 | 0.41 | 0.19 | 0.15 | 0.22 | 0.02 | Upgrade
|
| Common Stock | 3.51 | 3.51 | 3.5 | 3.5 | 3.49 | 0 | Upgrade
|
| Additional Paid-In Capital | 35.91 | 35.91 | 35.34 | 34.92 | 32.57 | 1.59 | Upgrade
|
| Retained Earnings | -10.4 | -10.04 | -7.87 | -6.15 | -5.52 | -1.6 | Upgrade
|
| Comprehensive Income & Other | -29.29 | -29.3 | -29.46 | -29.63 | -29.61 | - | Upgrade
|
| Shareholders' Equity | -0.28 | 0.08 | 1.51 | 2.64 | 0.94 | -0.01 | Upgrade
|
| Total Liabilities & Equity | 0.26 | 0.49 | 1.69 | 2.79 | 1.16 | 0.01 | Upgrade
|
| Total Debt | 0.15 | - | - | - | - | 0.01 | Upgrade
|
| Net Cash (Debt) | 0.03 | 0.39 | 1.56 | 0.48 | 0.88 | -0 | Upgrade
|
| Net Cash Growth | -96.08% | -75.14% | 225.73% | -45.37% | - | - | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 396.39 | 396.39 | 363.84 | 339.8 | 253.45 | 0.49 | Upgrade
|
| Total Common Shares Outstanding | 396.39 | 396.39 | 363.84 | 339.8 | 253.45 | 0.49 | Upgrade
|
| Working Capital | -0.28 | 0.08 | 1.51 | 0.56 | 0.74 | -0.01 | Upgrade
|
| Book Value Per Share | -0.00 | 0.00 | 0.00 | 0.01 | 0.00 | -0.02 | Upgrade
|
| Tangible Book Value | -0.28 | 0.08 | 1.51 | 0.56 | 0.74 | -0.01 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.